(Total Views: 121)
Posted On: 02/02/2024 8:08:42 AM
Post# of 32
ASPIRA WOMEN’S HEALTH: IMPROVING OVARIAN CANCER DETECTION
$AWH
Excited to share an article about Aspira Women’s Health Inc (NASDAQ: AWH), a bio-analytical-based women's health company focused on developing gynecologic disease diagnostic tools. Aspira's total revenue was $8.2 million for FY22, an increase of 20% compared to $6.8 million for FY21. Gross profit margin was 53% for FY22 compared to 45% for FY21.
The Company has a $1B pipeline opportunity for blood tests in ovarian cancer and endometriosis, and the Company is likely to see increased revenue growth due to its one-of-a-kind predictive tests. This makes Aspira an interesting watch.
Read on to know more:
https://www.aviseanalytics.com/aspiras-womens...detection/
$AWH
Excited to share an article about Aspira Women’s Health Inc (NASDAQ: AWH), a bio-analytical-based women's health company focused on developing gynecologic disease diagnostic tools. Aspira's total revenue was $8.2 million for FY22, an increase of 20% compared to $6.8 million for FY21. Gross profit margin was 53% for FY22 compared to 45% for FY21.
The Company has a $1B pipeline opportunity for blood tests in ovarian cancer and endometriosis, and the Company is likely to see increased revenue growth due to its one-of-a-kind predictive tests. This makes Aspira an interesting watch.
Read on to know more:
https://www.aviseanalytics.com/aspiras-womens...detection/
(0)
(0)
